L Ebony Boulware1, Kathryn A Carson, Misty U Troll, Neil R Powe, Lisa A Cooper. 1. Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Welch Center for Prevention, Epidemiology and Clinical Research, 2024 E. Monument Street, Baltimore, MD 21205, USA. lboulwa@jhmi.edu
Abstract
BACKGROUND: Patients' views of their risk for the development or progression of chronic kidney disease (CKD) are poorly characterized. OBJECTIVE: To assess perceived risk and concern regarding CKD development or progression among high-risk patients seen in primary care, identify predictors of perceptions, and correlate perceptions with adherence to high blood pressure management. DESIGN AND PARTICIPANTS: Cross-sectional study of 195 patients enrolled in a randomized controlled trial on hypertension management in 40 Maryland primary care practices. MEASUREMENTS: We assessed independent predictors (sociodemographics, health literacy, clinical presence of CKD, co-morbid conditions, and health behaviors) of perceived susceptibility (assessed via questionnaire) and adherence (assessed via Hill-Bone blood pressure adherence scale) in multivariable analyses. MAIN RESULTS: In this hypertensive majority African American (63%) population, many participants had uncontrolled blood pressure (44%) or diabetes (42%). Few (20%) felt "very likely" to develop CKD and one third (33%) were "very concerned" about developing CKD. Participants who were female and had low health literacy had lower perceived susceptibility to CKD compared to males and those with higher health literacy. Race and diabetes were also associated with perceived susceptibility. Greater perceived susceptibility was associated with poorer blood pressure management adherence scores. CONCLUSIONS: Many high-risk patients have low perceived susceptibility to CKD. Poor blood pressure therapy adherence scores among those with greatest perceived susceptibility suggest fatalistic attitudes about CKD. If our findings are confirmed in larger studies, interventions targeting patient perceptions of CKD risk and other attitudes associated with these perceptions could impact adherence to therapies and health outcomes.
RCT Entities:
BACKGROUND:Patients' views of their risk for the development or progression of chronic kidney disease (CKD) are poorly characterized. OBJECTIVE: To assess perceived risk and concern regarding CKD development or progression among high-risk patients seen in primary care, identify predictors of perceptions, and correlate perceptions with adherence to high blood pressure management. DESIGN AND PARTICIPANTS: Cross-sectional study of 195 patients enrolled in a randomized controlled trial on hypertension management in 40 Maryland primary care practices. MEASUREMENTS: We assessed independent predictors (sociodemographics, health literacy, clinical presence of CKD, co-morbid conditions, and health behaviors) of perceived susceptibility (assessed via questionnaire) and adherence (assessed via Hill-Bone blood pressure adherence scale) in multivariable analyses. MAIN RESULTS: In this hypertensive majority African American (63%) population, many participants had uncontrolled blood pressure (44%) or diabetes (42%). Few (20%) felt "very likely" to develop CKD and one third (33%) were "very concerned" about developing CKD. Participants who were female and had low health literacy had lower perceived susceptibility to CKD compared to males and those with higher health literacy. Race and diabetes were also associated with perceived susceptibility. Greater perceived susceptibility was associated with poorer blood pressure management adherence scores. CONCLUSIONS: Many high-risk patients have low perceived susceptibility to CKD. Poor blood pressure therapy adherence scores among those with greatest perceived susceptibility suggest fatalistic attitudes about CKD. If our findings are confirmed in larger studies, interventions targeting patient perceptions of CKD risk and other attitudes associated with these perceptions could impact adherence to therapies and health outcomes.
Authors: Janice P Lea; William M McClellan; Charlene Melcher; Elisa Gladstone; Tom Hostetter Journal: Am J Kidney Dis Date: 2006-01 Impact factor: 8.860
Authors: K Allen Greiner; Aimee S James; Wendi Born; Sandra Hall; Kimberly K Engelman; Kolawole S Okuyemi; Jasjit S Ahluwalia Journal: Prev Med Date: 2005-08 Impact factor: 4.018
Authors: Melanie K Haroun; Bernard G Jaar; Sandra C Hoffman; George W Comstock; Michael J Klag; Josef Coresh Journal: J Am Soc Nephrol Date: 2003-11 Impact factor: 10.121
Authors: Ruth E Davis; Gina Dolan; Sue Thomas; Christine Atwell; Donna Mead; Sarah Nehammer; Laurie Moseley; Adrian Edwards; Glyn Elwyn Journal: Health Expect Date: 2003-09 Impact factor: 3.377
Authors: Lisa A Cooper; Debra L Roter; Lee R Bone; Susan M Larson; Edgar R Miller; Michael S Barr; Kathryn A Carson; David M Levine Journal: Implement Sci Date: 2009-02-19 Impact factor: 7.327
Authors: Kerri L Cavanaugh; Rebecca L Wingard; Raymond M Hakim; Svetlana Eden; Ayumi Shintani; Kenneth A Wallston; Mary Margaret Huizinga; Tom A Elasy; Russell L Rothman; T Alp Ikizler Journal: J Am Soc Nephrol Date: 2010-07-29 Impact factor: 10.121
Authors: Julie A Wright; Kenneth A Wallston; Tom A Elasy; T Alp Ikizler; Kerri L Cavanaugh Journal: Am J Kidney Dis Date: 2010-12-18 Impact factor: 8.860
Authors: Delphine S Tuot; Laura C Plantinga; Chi-Yuan Hsu; Regina Jordan; Nilka Ríos Burrows; Elizabeth Hedgeman; Jerry Yee; Rajiv Saran; Neil R Powe Journal: Clin J Am Soc Nephrol Date: 2011-07-22 Impact factor: 8.237
Authors: Ebele M Umeukeje; Marcus G Wild; Saugar Maripuri; Teresa Davidson; Margaret Rutherford; Khaled Abdel-Kader; Julia Lewis; Consuelo H Wilkins; Kerri Cavanaugh Journal: Clin J Am Soc Nephrol Date: 2018-03-15 Impact factor: 8.237